Trending...
- Spokane: Council to Hold Press Conference to Discuss Further Information on Department of Justice Grant
- TBM Council Appoints U.S. Department of Transportation CDIO Pavan Pidugu to Board of Directors
- Tacoma Police Arrest Suspect in Series of Robberies Targeting Elderly Women
THE WOODLANDS, Texas - Washingtoner -- TCB Capital Advisors proudly announces two of its partners, Altoida Inc. and Gregor Diagnostics Inc., have been recognized by the 2024 Merit Awards for Healthcare. These awards celebrate companies demonstrating groundbreaking advancements in medical technology, healthcare innovation, and patient care.
Altoida received the Gold Award for "Best Use of Artificial Intelligence," a testament to its leadership in digital health and AI applications that enhance the early detection of neurodegenerative diseases, including Alzheimer's. Altoida's pioneering NeuroMarker Platform utilizes a tablet-based application powered by augmented reality (AR) and artificial intelligence/machine learning (AI/ML) designed to deliver rapid and objective multi-modal assessment of cognitive health and function. The platform aim's to equip frontline clinicians with clinical insights to enable earlier detection, personalized care and to lead to improved patient outcomes.
Gregor Diagnostics earned the Bronze Award in the "Innovations" category, underscoring the company's achievements in developing revolutionary diagnostic solutions. Gregor Diagnostics is dedicated to pioneering advancements in prostate cancer detection, aiming to deliver earlier and more precise diagnostics for better patient outcomes.
More on Washingtoner
"It's truly an honor to see Altoida and Gregor Diagnostics acknowledged for their groundbreaking work," Sam Libby, President and Managing Director at TCB Capital Advisors, expressed. "The Merit Awards spotlight innovators who are reshaping the future of healthcare, and we at TCB are so proud to support such visionary leaders who are driving remarkable advancements in patient care and medical science."
The 2024 Merit Awards for Healthcare highlights outstanding achievements across various healthcare sectors, selecting winners based on their significant impact on improving healthcare delivery and innovation.
For more information please visit Altoida and Gregor Diagnostics. To learn more about TCB Capital Advisors, visit TCB Capital Advisors.
About Altoida
Altoida is the leader in developing digital biomarkers for neurological conditions, including Alzheimer's disease. Its innovative Altoida Digital NeuroMarker Platform leverages artificial intelligence and augmented reality (AR) to deliver objective and precise assessments of cognitive health. The platform uses a tablet-based app that offers a quick, self-administered series of motor, speech, and AR tasks, simulating daily activities to evaluate brain health. These tasks measure key cognitive metrics, including micro-movements, processing speed, reaction time, and spatial navigation. Altoida is a privately held, venture-backed diagnostics company with a proprietary platform built on over 20 years of scientific research. Its evidence-based technology has been featured in numerous global pharmaceutical studies and published in prestigious peer-reviewed journals, including Nature Digital Medicine.
More on Washingtoner
About Gregor Diagnostics
Gregor Diagnostics Inc. is a molecular diagnostics company developing groundbreaking diagnostics for prostate cancer. Gregor Diagnostics' patient-friendly test is sensitive enough to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer upon detection. Gregor Diagnostics is making early detection and less invasive identification and management of prostate cancer a reality while decreasing the overdiagnosis and overtreatment of indolent prostate cancer.
About TCB Capital Advisors
TCB Capital Advisors is a boutique investment bank and advisory firm focused on the healthcare and life sciences sectors. The firm specializes in advising clients with their buying, selling, investment, and growth strategies, leveraging decades of combined Wall Street and industry experience. TCB Capital Advisors offers a tailored approach, focusing on transaction advisory, corporate development, revenue growth, and post-transaction integration, working with clients across venture, growth, and middle-market verticals. Founded in 2023 by former members of the healthcare team at Piper Sandler, TCB Capital Advisors is headquartered in Houston, TX with offices/team members based in New York, North Carolina, and Tennessee. Securities are offered through Finalis Securities, LLC (member FINRA/SIPC). TCB Capital Advisors is not a registered broker-dealer, and Finalis Securities, LLC and TCB Capital Advisors are separated, unaffiliated entities. For more information, please visit www.tcbcapitaladvisors.com.
Altoida received the Gold Award for "Best Use of Artificial Intelligence," a testament to its leadership in digital health and AI applications that enhance the early detection of neurodegenerative diseases, including Alzheimer's. Altoida's pioneering NeuroMarker Platform utilizes a tablet-based application powered by augmented reality (AR) and artificial intelligence/machine learning (AI/ML) designed to deliver rapid and objective multi-modal assessment of cognitive health and function. The platform aim's to equip frontline clinicians with clinical insights to enable earlier detection, personalized care and to lead to improved patient outcomes.
Gregor Diagnostics earned the Bronze Award in the "Innovations" category, underscoring the company's achievements in developing revolutionary diagnostic solutions. Gregor Diagnostics is dedicated to pioneering advancements in prostate cancer detection, aiming to deliver earlier and more precise diagnostics for better patient outcomes.
More on Washingtoner
- Best Personal Injury Attorneys Of 2025 - ELA Awards
- Best Personal Injury Law Firms 2025 - ELA Awards
- Baruch Arcade Launches AI-Powered Gaming Platform on Solana, do I smell an airdrop?
- Arux Group Launches WA Security Training Programs
- Expert Law Attorneys 2025 Best Attorneys
"It's truly an honor to see Altoida and Gregor Diagnostics acknowledged for their groundbreaking work," Sam Libby, President and Managing Director at TCB Capital Advisors, expressed. "The Merit Awards spotlight innovators who are reshaping the future of healthcare, and we at TCB are so proud to support such visionary leaders who are driving remarkable advancements in patient care and medical science."
The 2024 Merit Awards for Healthcare highlights outstanding achievements across various healthcare sectors, selecting winners based on their significant impact on improving healthcare delivery and innovation.
For more information please visit Altoida and Gregor Diagnostics. To learn more about TCB Capital Advisors, visit TCB Capital Advisors.
About Altoida
Altoida is the leader in developing digital biomarkers for neurological conditions, including Alzheimer's disease. Its innovative Altoida Digital NeuroMarker Platform leverages artificial intelligence and augmented reality (AR) to deliver objective and precise assessments of cognitive health. The platform uses a tablet-based app that offers a quick, self-administered series of motor, speech, and AR tasks, simulating daily activities to evaluate brain health. These tasks measure key cognitive metrics, including micro-movements, processing speed, reaction time, and spatial navigation. Altoida is a privately held, venture-backed diagnostics company with a proprietary platform built on over 20 years of scientific research. Its evidence-based technology has been featured in numerous global pharmaceutical studies and published in prestigious peer-reviewed journals, including Nature Digital Medicine.
More on Washingtoner
- Best Family Law Attorneys Of 2025 - ELA Awards
- Best Criminal Defense Attorneys Of 2025 - ELA Awards
- Americans Need $1.26 Million to Retire But Have Just $38K Saved — So They're Building Income Instead
- Does EMDR Really Work? New Article Explores How Trauma Gets Stuck in the Brain and How Healing Begins
- New Medium Article Explores Why Emotional Conversations Fail and What Most People Don't Understand About Connection
About Gregor Diagnostics
Gregor Diagnostics Inc. is a molecular diagnostics company developing groundbreaking diagnostics for prostate cancer. Gregor Diagnostics' patient-friendly test is sensitive enough to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer upon detection. Gregor Diagnostics is making early detection and less invasive identification and management of prostate cancer a reality while decreasing the overdiagnosis and overtreatment of indolent prostate cancer.
About TCB Capital Advisors
TCB Capital Advisors is a boutique investment bank and advisory firm focused on the healthcare and life sciences sectors. The firm specializes in advising clients with their buying, selling, investment, and growth strategies, leveraging decades of combined Wall Street and industry experience. TCB Capital Advisors offers a tailored approach, focusing on transaction advisory, corporate development, revenue growth, and post-transaction integration, working with clients across venture, growth, and middle-market verticals. Founded in 2023 by former members of the healthcare team at Piper Sandler, TCB Capital Advisors is headquartered in Houston, TX with offices/team members based in New York, North Carolina, and Tennessee. Securities are offered through Finalis Securities, LLC (member FINRA/SIPC). TCB Capital Advisors is not a registered broker-dealer, and Finalis Securities, LLC and TCB Capital Advisors are separated, unaffiliated entities. For more information, please visit www.tcbcapitaladvisors.com.
Source: TCB Capital Advisors
0 Comments
Latest on Washingtoner
- STATEMENT: Shincheonji on Religious Freedom Controversy
- SheRising: Friends in Solidarity Hosts Webinar on Women in South Sudan
- Spokane: Arrest Made After Downtown Shoplifting Incident Turns Into Robbery
- GlobalBoost Media Announces Recent $BSTY Exchange Listings and Upcoming BTCC Integration
- Cyntexa Outlines a Principles-first Approach to Modern Enterprise Transformation
- Kickstarter And Creator Camp Partner To Support A New Era Of Creator-led Independent Film
- Top 66 People-Centric Leaders of 2025 Prove Taking Care of People Is Taking Care of Business
- Kliemann Brothers Announces 2025 Furnace Giveaway Winners
- Spokane: Coffee With Council District 2 Council Members
- RNHA Celebrates One Year In, President Trump — the American Comeback Is Underway
- Daniel Kaufman Launches a Vertically Integrated Real Estate and Investment Platform
- Long Long Tales: Bilingual Cartoon Series on Youtube Celebrating Chinese New Year
- MAX Illumination Redefines Cabinet Displays with New Edge-Lit LED Technology
- Impact Futures Group expands through acquisition of specialist healthcare sector training provider Caring for Care
- Junetini Unveils Grown & Sexy 80 Proof Blanco Tequila
- Tacoma Police Arrest Suspect in Series of Robberies Targeting Elderly Women
- CPPS Announces Team Growth and Leadership Updates
- FeedSocially - Post Once, Publish Everywhere
- James D. Harding Promoted to Century Fasteners Corp. – Managing Director
- Finland's New Gambling Watchdog Handed Sweeping Powers to Revoke Licenses and Block Illegal Casino Sites